Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
在缺氧微环境中靶向脑肿瘤干细胞
基本信息
- 批准号:10071001
- 负责人:
- 金额:$ 30.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Locally reduced oxygen levels are a feature of many malignancies, particularly those which grow rapidly. One cancer in which hypoxia-induced necrosis and neovascularization is central to pathological diagnosis is glioblastoma the most common malignant brain tumor. Hypoxic regions are frequent in glioblastoma, and increased levels of tumor hypoxia have been associated with worse clinical outcomes. In this proposal, we focus on functionally important links between hypoxia, the monocarboxylate transporter-4 (MCT4), and Notch and their role in promoting the growth and survival of stem-like glioma cells (GSC) in malignant brain tumors for which there is no cure. In the first aim we determine how Notch is regulated by MCT4. In Aim 2, we will study the relationship between Notch and GSC in the hypoxic microenvironment. Finally, in Aim 3 we will focus on potential mechanism by which MCT4 may regulate GSC radiation sensitivity. These studies build directly on recent work from our group linking hypoxia, Notch, and MCT4 to stem cell induction and address the role of MCT4 in mediating critical aspects of the hypoxic response. An important component of our strategy is using novel constructs to manipulate and measure the molecular response to hypoxia and Notch signaling. We hope that these studies will lay the foundation for direct translation into clinical therapeutic trials.
描述(申请人提供):局部氧气水平降低是许多恶性肿瘤的特征,尤其是那些生长迅速的肿瘤。最常见的恶性脑肿瘤--胶质母细胞瘤是一种以缺氧引起的坏死和新生血管为中心的肿瘤。低氧区域在胶质母细胞瘤中很常见,肿瘤低氧水平的增加与较差的临床结果相关。在这项研究中,我们将重点放在低氧、单羧酸转运体-4(MCT4)和Notch之间在功能上的重要联系,以及它们在促进干细胞样脑胶质瘤细胞(GSC)生长和存活中的作用,这些肿瘤目前还无法治愈。在第一个目标中,我们确定Notch是如何由MCT4调节的。在目标2中,我们将研究缺氧微环境中Notch与GSC的关系。最后,在目标3中,我们将重点介绍MCT4调节GSC辐射敏感性的潜在机制。这些研究直接建立在我们团队最近的工作基础上,将低氧、Notch和MCT4与干细胞诱导联系起来,并解决了MCT4在调节低氧反应的关键方面的作用。我们策略的一个重要组成部分是使用新的结构来操纵和测量分子对缺氧和Notch信号的反应。我们希望这些研究将为直接转化为临床治疗试验奠定基础。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression.
- DOI:10.1038/s41598-017-04612-w
- 发表时间:2017-06-27
- 期刊:
- 影响因子:4.6
- 作者:Voss DM;Spina R;Carter DL;Lim KS;Jeffery CJ;Bar EE
- 通讯作者:Bar EE
MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent manner.
MCT4 以不依赖于乳酸的方式调节 GBM 中的从头嘧啶生物合成。
- DOI:10.1093/noajnl/vdz062
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Spina,Raffaella;Voss,DillonM;Yang,Xiaohua;Sohn,JasonW;Vinkler,Robert;Schraner,Julianna;Sloan,Anthony;Welford,ScottM;Avril,Norbert;Ames,HeatherM;Woodworth,GraemeF;Bar,EliE
- 通讯作者:Bar,EliE
Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
- DOI:10.18632/oncotarget.6314
- 发表时间:2016-01-05
- 期刊:
- 影响因子:0
- 作者:Spina R;Voss DM;Asnaghi L;Sloan A;Bar EE
- 通讯作者:Bar EE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eli E Bar其他文献
Eli E Bar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
- 批准号:81801389
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
- 批准号:81101046
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of metastatic brain tumor development by targeting CD276-expressing M2 macrophages
通过靶向表达 CD276 的 M2 巨噬细胞调节转移性脑肿瘤的发展
- 批准号:
22K15613 - 财政年份:2022
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10164550 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10581652 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Targeting tumor-neural cell interactions to inhibit lung cancer brain metastasis
靶向肿瘤-神经细胞相互作用抑制肺癌脑转移
- 批准号:
10366021 - 财政年份:2021
- 资助金额:
$ 30.8万 - 项目类别:
Novel PET probe for brain tumor imaging targeting specifically expressed enzymes
针对特定表达酶的脑肿瘤成像新型 PET 探针
- 批准号:
20K21260 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of novel tumor-targeting nanoparticles for malignant brain tumor neutron capture therapy and diagnosis
开发用于恶性脑肿瘤中子捕获治疗和诊断的新型肿瘤靶向纳米颗粒
- 批准号:
20K07672 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel immunotherapy for malignant brain tumors targeting tumor vascular mimicry
针对肿瘤血管拟态的恶性脑肿瘤新型免疫疗法的开发
- 批准号:
20K07187 - 财政年份:2020
- 资助金额:
$ 30.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting brain tumor initiating cell-specific super-enhancer associated genes to treat glioblastoma
靶向脑肿瘤启动细胞特异性超级增强子相关基因治疗胶质母细胞瘤
- 批准号:
10176425 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
Targeting brain tumor initiating cell-specific super-enhancer associated genes to treat glioblastoma
靶向脑肿瘤启动细胞特异性超级增强子相关基因治疗胶质母细胞瘤
- 批准号:
10426141 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别:
Targeting brain tumor initiating cell-specific super-enhancer associated genes to treat glioblastoma
靶向脑肿瘤启动细胞特异性超级增强子相关基因治疗胶质母细胞瘤
- 批准号:
9980173 - 财政年份:2019
- 资助金额:
$ 30.8万 - 项目类别: